What’s next for health insurers
David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...
On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...
“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many ...
Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...
A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense) seeds and their oil, ...
UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...
A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense ) seeds and their oil, ...
Corn crops have a voracious appetite for nitrogen. Purdue University scientists are investigating whether mulching Kura ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
UnitedHealth (NYSE:UNH) reported better-than-expected financials for Q3 2024 on Tuesday. However, shares of the managed care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback